Researchers will begin human trials of a new treatment for type 1 diabetes that can cure the disease and stop the need for painful insulin injections.
Experts at St. Vincent’s Institute for Medical Research (SVI) in Melbourne will determine whether paricinib can stop the immune system from destroying the insulin-producing cells of people diagnosed with type 1 diabetes
Professor Helen Thomas explained that this would allow people newly diagnosed with the disease to continue producing insulin for a longer period and improve their glucose control.
Persons between the ages of 12 and 30 who were recently diagnosed with type 1 diabetes are being recruited to participate in the trial
Seven Australians are diagnosed with the disease every day and rely on often painful insulin injections to regulate their blood sugar levels.
Other long-term complications of the condition include heart attack, stroke, poor eyesight, kidney disease, and nerve damage.
“It’s very exciting for us to be the first group anywhere in the world to test the effectiveness of baritinib as a potential treatment for type 1 diabetes,” said SVI Director Professor Tom Kay
“If the experiment proves successful, insulin production will be preserved and people with type 1 diabetes will become less dependent on insulin therapy”
The trial will be conducted at Royal Melbourne Hospital, Royal Children’s Hospital and St. Vincent’s Hospital
Type 1 Diabetes, Diabetes, and Insulin
World News – African Union – An innovative treatment that can treat type 1 diabetes and stop the need for insulin injections
Related Title :
– <a href="/?s=Melbourne Researchers to test whether the new treatment can treat type 1 diabetes "Researchers Melbourne to test whether a new treatment can cure type 1 diabetes
– first global trial To stop type 1 diabetes patients who need insulin